Somatostatin receptor 2 targeting in small cell lung carcinoma: perspectives

Small Cell lung carcinoma (SCLC) is the most lethal and aggressive subtype of lung cancer. Novel targeting approaches and agents are desperately needed. In this perspectives, we briefly explore recent data published in the International Journal of Cancer suggesting Somatostatin Receptor 2 (SSTR2) as...

Descripción completa

Detalles Bibliográficos
Autores principales: Lehman, Jonathan M., aMassion, Pierre P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677662/
https://www.ncbi.nlm.nih.gov/pubmed/31413814
http://dx.doi.org/10.18632/oncotarget.27107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677662/
https://www.ncbi.nlm.nih.gov/pubmed/31413814
http://dx.doi.org/10.18632/oncotarget.27107

Ejemplares similares